Pendal Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $631K | Sell |
|
|||||
|
2022
Q3 | $924K | Buy |
|
|||||
|
2022
Q2 | $974K | Sell |
|
|||||
|
2022
Q1 | $2.72M | Hold |
|
|||||
|
2021
Q4 | $2.32M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $1.06M | Sell |
|
|||||
|
2021
Q1 | $1.75M | Sell |
|
|||||
|
2020
Q4 | $2.12M | Sell |
|
|||||
|
2020
Q3 | $3.6M | Buy |
|
|||||
|
2020
Q2 | $1.58M | Buy |
|
|||||
|
2020
Q1 | $886K | Sell |
|
|||||
|
2019
Q4 | $4.05M | Buy |
|
|||||
|
2019
Q3 | $172K | Sell |
|
|||||
|
2019
Q2 | $10.3M | Sell |
|
|||||
|
2019
Q1 | $17.6M | Buy |
|
|||||
|
2018
Q4 | $17.8M | Buy |
|
|||||
|
2018
Q3 | $11M | Sell |
|
|||||
|
2018
Q2 | $13.2M | Buy |
|
|||||
|
2018
Q1 | $12.3M | Sell |
|
|||||
|
2017
Q4 | $13.1M | Buy |
|
|||||
|
2017
Q3 | $10.5M | Buy |
|
|||||
|
2017
Q2 | $6.04M | Buy |
|